New Shingles Vaccine Available
Following the FDA approval in October of Shingrix (Zoster Vaccine Recombinant, Adjuvanated), GSK announced the CDC's Advisory Committee on Immunization Practices (ACIP) recommends Shingrix as the preferred vaccine for the prevention of shingles for adults aged 50 and up. The new recommendation means up to...